EIRJul 15, 2022
EIR Document: Revance Therapeutics Inc


Establishment Inspection Report for the FDA inspection at Revance Therapeutics Inc's Newark site on Jul 15, 2022. Get detailed insights.


Establishment Inspection Report for the FDA inspection at Revance Therapeutics Inc's Newark site on Jul 15, 2022. Get detailed insights.